Advances in Environmental Epidemiology
Identifieur interne :
002118 ( PascalFrancis/Curation );
précédent :
002117;
suivant :
002119
Advances in Environmental Epidemiology
Auteurs : Caroline M. Tanner [
États-Unis]
Source :
-
Movement disorders [ 0885-3185 ] ; 2010.
RBID : Pascal:10-0193327
Descripteurs français
English descriptors
Abstract
Parkinson's disease (PD) is likely due to the combined effects of environment and genes in most cases. Environmental factors inversely associated with PD (or, putative protective factors) include cigarette smoking, use of coffee/caffeine, higher uric acid levels, and anti-inflammatory drug use. Less well-established inverse associations with PD include higher cholesterol levels, statin use, higher dietary vitamin B6, and night shift work. Putative risk factors are pesticide exposure, head trauma, certain occupations, and milk consumption. The pathogenesis of PD may begin decades before motor symptoms. PD may have shared determinants with other neurodegenerative disorders involving abnormal protein aggregation.
| pA |
| A01 | 01 | 1 | | @0 0885-3185 |
|---|
| A03 | | 1 | | @0 Mov. disord. |
|---|
| A05 | | | | @2 25 |
|---|
| A06 | | | | @2 3 @3 SUP1 |
|---|
| A08 | 01 | 1 | ENG | @1 Advances in Environmental Epidemiology |
|---|
| A09 | 01 | 1 | ENG | @1 Frontiers of Science and Clinical Advances in Quality of Life in Parkinson's Disease |
|---|
| A11 | 01 | 1 | | @1 TANNER (Caroline M.) |
|---|
| A12 | 01 | 1 | | @1 FAHN (Stanley) @9 ed. |
|---|
| A12 | 02 | 1 | | @1 MARDER (Karen) @9 ed. |
|---|
| A12 | 03 | 1 | | @1 COTE (Lucien) @9 ed. |
|---|
| A12 | 04 | 1 | | @1 REICH (Stephen G.) @9 ed. |
|---|
| A14 | 01 | | | @1 Clinical Research, The Parkinson's Institute @2 Sunnyvale, California @3 USA @Z 1 aut. |
|---|
| A15 | 01 | | | @1 Department of Neurology, Columbia University College of Physicians and Surgeons @2 New York, New York @3 USA @Z 1 aut. |
|---|
| A18 | 01 | 1 | | @1 Parkinson's Disease Foundation @2 New York, NY @3 USA @9 org-cong. |
|---|
| A20 | | | | @2 S58-S62 |
|---|
| A21 | | | | @1 2010 |
|---|
| A23 | 01 | | | @0 ENG |
|---|
| A43 | 01 | | | @1 INIST @2 20953 @5 354000189676130090 |
|---|
| A44 | | | | @0 0000 @1 © 2010 INIST-CNRS. All rights reserved. |
|---|
| A45 | | | | @0 79 ref. |
|---|
| A47 | 01 | 1 | | @0 10-0193327 |
|---|
| A60 | | | | @1 P @2 C |
|---|
| A61 | | | | @0 A |
|---|
| A64 | 01 | 1 | | @0 Movement disorders |
|---|
| A66 | 01 | | | @0 USA |
|---|
| C01 | 01 | | ENG | @0 Parkinson's disease (PD) is likely due to the combined effects of environment and genes in most cases. Environmental factors inversely associated with PD (or, putative protective factors) include cigarette smoking, use of coffee/caffeine, higher uric acid levels, and anti-inflammatory drug use. Less well-established inverse associations with PD include higher cholesterol levels, statin use, higher dietary vitamin B6, and night shift work. Putative risk factors are pesticide exposure, head trauma, certain occupations, and milk consumption. The pathogenesis of PD may begin decades before motor symptoms. PD may have shared determinants with other neurodegenerative disorders involving abnormal protein aggregation. |
|---|
| C02 | 01 | X | | @0 002B17 |
|---|
| C02 | 02 | X | | @0 002A16F |
|---|
| C03 | 01 | X | FRE | @0 Maladie de Parkinson @2 NM @5 01 |
|---|
| C03 | 01 | X | ENG | @0 Parkinson disease @2 NM @5 01 |
|---|
| C03 | 01 | X | SPA | @0 Parkinson enfermedad @2 NM @5 01 |
|---|
| C03 | 02 | X | FRE | @0 Pathologie du système nerveux @5 02 |
|---|
| C03 | 02 | X | ENG | @0 Nervous system diseases @5 02 |
|---|
| C03 | 02 | X | SPA | @0 Sistema nervioso patología @5 02 |
|---|
| C03 | 03 | X | FRE | @0 Epidémiologie @5 09 |
|---|
| C03 | 03 | X | ENG | @0 Epidemiology @5 09 |
|---|
| C03 | 03 | X | SPA | @0 Epidemiología @5 09 |
|---|
| C03 | 04 | X | FRE | @0 Environnement @5 10 |
|---|
| C03 | 04 | X | ENG | @0 Environment @5 10 |
|---|
| C03 | 04 | X | SPA | @0 Medio ambiente @5 10 |
|---|
| C07 | 01 | X | FRE | @0 Pathologie de l'encéphale @5 37 |
|---|
| C07 | 01 | X | ENG | @0 Cerebral disorder @5 37 |
|---|
| C07 | 01 | X | SPA | @0 Encéfalo patología @5 37 |
|---|
| C07 | 02 | X | FRE | @0 Syndrome extrapyramidal @5 38 |
|---|
| C07 | 02 | X | ENG | @0 Extrapyramidal syndrome @5 38 |
|---|
| C07 | 02 | X | SPA | @0 Extrapiramidal síndrome @5 38 |
|---|
| C07 | 03 | X | FRE | @0 Maladie dégénérative @5 39 |
|---|
| C07 | 03 | X | ENG | @0 Degenerative disease @5 39 |
|---|
| C07 | 03 | X | SPA | @0 Enfermedad degenerativa @5 39 |
|---|
| C07 | 04 | X | FRE | @0 Pathologie du système nerveux central @5 40 |
|---|
| C07 | 04 | X | ENG | @0 Central nervous system disease @5 40 |
|---|
| C07 | 04 | X | SPA | @0 Sistema nervosio central patología @5 40 |
|---|
| N21 | | | | @1 130 |
|---|
| N44 | 01 | | | @1 OTO |
|---|
| N82 | | | | @1 OTO |
|---|
|
|---|
| pR |
| A30 | 01 | 1 | ENG | @1 Symposium of the Parkinson's Disease Foundation @3 South Street Seaport, Manhattan USA @4 2007-10-11 |
|---|
|
|---|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000C01
Links to Exploration step
Pascal:10-0193327
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Advances in Environmental Epidemiology</title>
<author><name sortKey="Tanner, Caroline M" sort="Tanner, Caroline M" uniqKey="Tanner C" first="Caroline M." last="Tanner">Caroline M. Tanner</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Clinical Research, The Parkinson's Institute</s1>
<s2>Sunnyvale, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14><country>États-Unis</country>
</affiliation><publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">10-0193327</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 10-0193327 INIST</idno>
<idno type="RBID">Pascal:10-0193327</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000C01</idno>
<idno type="wicri:Area/PascalFrancis/Curation">002118</idno>
</publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Advances in Environmental Epidemiology</title>
<author><name sortKey="Tanner, Caroline M" sort="Tanner, Caroline M" uniqKey="Tanner C" first="Caroline M." last="Tanner">Caroline M. Tanner</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Clinical Research, The Parkinson's Institute</s1>
<s2>Sunnyvale, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14><country>États-Unis</country>
</affiliation><series><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
<imprint><date when="2010">2010</date>
</imprint><seriesStmt><title level="j" type="main">Movement disorders</title>
<title level="j" type="abbreviated">Mov. disord.</title>
<idno type="ISSN">0885-3185</idno>
</seriesStmt><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Environment</term>
<term>Epidemiology</term>
<term>Nervous system diseases</term>
<term>Parkinson disease</term>
</keywords><keywords scheme="Pascal" xml:lang="fr"><term>Maladie de Parkinson</term>
<term>Pathologie du système nerveux</term>
<term>Epidémiologie</term>
<term>Environnement</term>
</keywords><front><div type="abstract" xml:lang="en">Parkinson's disease (PD) is likely due to the combined effects of environment and genes in most cases. Environmental factors inversely associated with PD (or, putative protective factors) include cigarette smoking, use of coffee/caffeine, higher uric acid levels, and anti-inflammatory drug use. Less well-established inverse associations with PD include higher cholesterol levels, statin use, higher dietary vitamin B6, and night shift work. Putative risk factors are pesticide exposure, head trauma, certain occupations, and milk consumption. The pathogenesis of PD may begin decades before motor symptoms. PD may have shared determinants with other neurodegenerative disorders involving abnormal protein aggregation.</div>
</front><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0885-3185</s0>
</fA01><fA03 i2="1"><s0>Mov. disord.</s0>
</fA03><fA06><s2>3</s2>
<s3>SUP1</s3>
</fA06><fA08 i1="01" i2="1" l="ENG"><s1>Advances in Environmental Epidemiology</s1>
</fA08><fA09 i1="01" i2="1" l="ENG"><s1>Frontiers of Science and Clinical Advances in Quality of Life in Parkinson's Disease</s1>
</fA09><fA11 i1="01" i2="1"><s1>TANNER (Caroline M.)</s1>
</fA11><fA12 i1="01" i2="1"><s1>FAHN (Stanley)</s1>
<s9>ed.</s9>
</fA12><fA12 i1="02" i2="1"><s1>MARDER (Karen)</s1>
<s9>ed.</s9>
</fA12><fA12 i1="03" i2="1"><s1>COTE (Lucien)</s1>
<s9>ed.</s9>
</fA12><fA12 i1="04" i2="1"><s1>REICH (Stephen G.)</s1>
<s9>ed.</s9>
</fA12><fA14 i1="01"><s1>Clinical Research, The Parkinson's Institute</s1>
<s2>Sunnyvale, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14><fA15 i1="01"><s1>Department of Neurology, Columbia University College of Physicians and Surgeons</s1>
<s2>New York, New York</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA15><fA18 i1="01" i2="1"><s1>Parkinson's Disease Foundation</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<s9>org-cong.</s9>
</fA18><fA20><s2>S58-S62</s2>
</fA20><fA21><s1>2010</s1>
</fA21><fA23 i1="01"><s0>ENG</s0>
</fA23><fA43 i1="01"><s1>INIST</s1>
<s2>20953</s2>
<s5>354000189676130090</s5>
</fA43><fA44><s0>0000</s0>
<s1>© 2010 INIST-CNRS. All rights reserved.</s1>
</fA44><fA45><s0>79 ref.</s0>
</fA45><fA47 i1="01" i2="1"><s0>10-0193327</s0>
</fA47><fA60><s1>P</s1>
<s2>C</s2>
</fA60><fA64 i1="01" i2="1"><s0>Movement disorders</s0>
</fA64><fA66 i1="01"><s0>USA</s0>
</fA66><fC01 i1="01" l="ENG"><s0>Parkinson's disease (PD) is likely due to the combined effects of environment and genes in most cases. Environmental factors inversely associated with PD (or, putative protective factors) include cigarette smoking, use of coffee/caffeine, higher uric acid levels, and anti-inflammatory drug use. Less well-established inverse associations with PD include higher cholesterol levels, statin use, higher dietary vitamin B6, and night shift work. Putative risk factors are pesticide exposure, head trauma, certain occupations, and milk consumption. The pathogenesis of PD may begin decades before motor symptoms. PD may have shared determinants with other neurodegenerative disorders involving abnormal protein aggregation.</s0>
</fC01><fC02 i1="01" i2="X"><s0>002B17</s0>
</fC02><fC02 i1="02" i2="X"><s0>002A16F</s0>
</fC02><fC03 i1="01" i2="X" l="FRE"><s0>Maladie de Parkinson</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03><fC03 i1="02" i2="X" l="FRE"><s0>Pathologie du système nerveux</s0>
<s5>02</s5>
</fC03><fC03 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>02</s5>
</fC03><fC03 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>02</s5>
</fC03><fC03 i1="03" i2="X" l="FRE"><s0>Epidémiologie</s0>
<s5>09</s5>
</fC03><fC03 i1="03" i2="X" l="ENG"><s0>Epidemiology</s0>
<s5>09</s5>
</fC03><fC03 i1="03" i2="X" l="SPA"><s0>Epidemiología</s0>
<s5>09</s5>
</fC03><fC03 i1="04" i2="X" l="FRE"><s0>Environnement</s0>
<s5>10</s5>
</fC03><fC03 i1="04" i2="X" l="ENG"><s0>Environment</s0>
<s5>10</s5>
</fC03><fC03 i1="04" i2="X" l="SPA"><s0>Medio ambiente</s0>
<s5>10</s5>
</fC03><fC07 i1="01" i2="X" l="FRE"><s0>Pathologie de l'encéphale</s0>
<s5>37</s5>
</fC07><fC07 i1="01" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>37</s5>
</fC07><fC07 i1="01" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>37</s5>
</fC07><fC07 i1="02" i2="X" l="FRE"><s0>Syndrome extrapyramidal</s0>
<s5>38</s5>
</fC07><fC07 i1="02" i2="X" l="ENG"><s0>Extrapyramidal syndrome</s0>
<s5>38</s5>
</fC07><fC07 i1="02" i2="X" l="SPA"><s0>Extrapiramidal síndrome</s0>
<s5>38</s5>
</fC07><fC07 i1="03" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>39</s5>
</fC07><fC07 i1="03" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>39</s5>
</fC07><fC07 i1="03" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>39</s5>
</fC07><fC07 i1="04" i2="X" l="FRE"><s0>Pathologie du système nerveux central</s0>
<s5>40</s5>
</fC07><fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07><fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07><fN21><s1>130</s1>
</fN21><fN44 i1="01"><s1>OTO</s1>
</fN44><fN82><s1>OTO</s1>
</fN82><pR><fA30 i1="01" i2="1" l="ENG"><s1>Symposium of the Parkinson's Disease Foundation</s1>
<s3>South Street Seaport, Manhattan USA</s3>
<s4>2007-10-11</s4>
</fA30>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002118 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 002118 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:10-0193327
|texte= Advances in Environmental Epidemiology
}}
| This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024 |  |
